MC3 Recorded Education Series: Prenatal Substance Use and Neuro-developmental Trajectories
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
- Participants will be able to identify the signs, symptoms, and risk factors of NOWS (Neonatal Opioid Withdrawal Syndrome) and be able to assess patients for this condition.
- Learners will be able to develop treatment options for mothers whose babies are at risk for NOWS.
- Participants will be able to manage the immediate and longer-term care of patients impacted by NOWS.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Original Release Date: October 2020
Termination Date: December 2023
Brown, Q., Sarvet, A., Shmulewitz, D., Martins, S., Wall, M., Hasin, D. (2017). Trends in Marijuana Use among Pregnant and Non-pregnant Reproductive-Aged Women, 2002-2014. JAMA. 317(2):207-211.
Jones, H., Kaltenbach, K., Heil, S., Stine, S., Coyle, M., Arria, A., O’Grady, K., Selby, P., Martin, P., Fischer, G. (2010). Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure. New England Journal of Medicine. 63(24):2320-2331.
Klaman, S., Ixaacs, K., Leopold, A., Perpich, J., Hayashi, S., Vender, J., Campopiano, M., Jones, H. (2017). Treating Women Who are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of their Infants and Children: Literature Review to Support National Guidance. Journal of Addiction Medicine. 11(3):178-190.
